INDIANAPOLIS (WISH) — Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with ...

Please provide your email address to receive an email when new articles are posted on . Pancytopenia occurred in more than 13% of patients with systemic lupus erythematosus receiving immune checkpoint ...

The breakthrough treatment could lead to safer cancer therapies and may also help treat autoimmune diseases like lupus ...

The team at Charité – Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer ...

Phase III results put obinutuzumab in line for approval ...

Short-term observational data support belimumab as a safe therapeutic option in patients with lupus nephritis, who are at increased risk of cancer. Over the short term, overall cancer risk may be ...

But one doctor after another failed to make the connection. She was told by one it was stress related and she should quit her job. Another congratulated her on the weight loss and said how much ...

AGOURA HILLS, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTLC) announced today the peer reviewed publication of Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in ...

InvestigateTV+ shares a young mother’s struggle with the debilitating effects of lupus. Plus, we take an in-depth look at what could become a breakthrough treatment.

When added to standard care, more lupus nephritis patients achieved complete remissions with obinutuzumab (Gazyva) than with placebo. Treatment was added to mycophenolate mofetil and glucocorticoids.

Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. In this Lupus & You recording, ...